Platform
Features
0 followers
Follow
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Nickolay V. Kukekov
0 members
HQ
0 people
Astellas Pharma
32 followers
AstraZeneca
315 followers
Novo Nordisk
278 followers
GSK
284 followers
Bayer
251 followers
Walgreens Boots Alliance
109 followers
University of Windsor
2 followers
UCB
30 followers
Jazz Pharmaceuticals
23 followers
Omnicell
21 followers
Organon
17 followers
Explore companies